老年人深静脉血栓治疗进展

doi:10.3969/j.issn.1003-9198.2025.09.001

Abstract

Abstract: With the escalation of population aging, the incidence of deep vein thrombosis (DVT) in elderly patients has significantly increased, emerging as a public health issue that seriously threatens the health and life of the elderly. This paper explores the epidemiological characteristics, high-risk factors and diagnostic processes, and expounds on the applicable scenarios, drug selection, and precautions of different treatment methods, including anticoagulant therapy, thrombolytic therapy, endovascular treatment, and compression therapy. It is emphasized that during the treatment process, the physiological characteristics, comorbidities, and drug interactions of elderly patients should be comprehensively considered to formulate individualized treatment plans, so as to improve treatment efficacy, reduce the incidence of complications, and enhance the quality of life and prognosis of elderly patients.

Key words: aged, deep vein thrombosis, epidemiology, diagnosis, treatment

CLC Number:

R 543.6

WANG Meijuan, JIANG Xuezhong, WANG Yi. Advances in the treatment of deep vein thrombosis in the elderly[J]. Practical Geriatrics, 2025, 39(9): 865-870.

References

[1] 曾保尧, 王斌强, 左江伟. 不同年龄和性别下肢深静脉血栓形成危险因素分析[J]. 中国现代医药杂志, 2020, 22(8): 12-18.
[2] NAESS I A, CHRISTIANSEN S C, ROMUNDSTAD P, et al. Incidence and mortality of venous thrombosis: a population-based study[J]. J Thromb Haemost, 2007, 5(4): 692-699.
[3] DELLUC A, TROMEUR C, LE VEN F, et al. Current incidence of venous thromboembolism and comparison with 1998: a community-based study in Western France[J]. Thromb Haemost, 2016, 116(5): 967-974.
[4] HEIT J A, ASHRANI A, CRUSAN D J, et al. Reasons for the persistent incidence of venous thromboembolism[J]. Thromb Haemost, 2017, 117(2): 390-400.
[5] 吴洲鹏, 李凤贺, 戴贻权, 等. 老年人静脉血栓栓塞症防治中国专家共识[J]. 中国普外基础与临床杂志, 2023, 30(10):1173-1187.
[6] MONREAL M, AGNELLI G, CHUANG L H, et al. Deep vein thrombosis in Europe-health-related quality of life and mortality[J]. Clin Appl Thromb Hemost, 2019, 25: 1076029619883946.
[7] BECKMAN M G, CRAIG HOOPER W, CRITCHLEY S E, et al. Venous thromboembolism: a public health concern[J]. Am J Prev Med, 2010, 38(4 Suppl): S495-S501.
[8] DINTENFASS L. Modifications of blood rheology during aging and age-related pathological conditions[J]. Aging: Milano, 1989, 1(2): 99-125.
[9] 马妍妍, 徐亚楠, 解华杰. 老年慢性阻塞性肺疾病急性加重期患者下肢深静脉血栓形成的危险因素分析[J]. 血管与腔内血管外科杂志, 2023,9(8): 917-921.
[10] KONSTANTINIDES S V, MEYER G, BECATTINI C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): the Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC) [J]. Eur Respir J, 2019, 54(3):1901647.
[11] YUAN J L, XIAO W K, ZHANG C Q, et al. Incidence and characteristic of deep venous thrombosis in hospitalized chronic heart failure patients[J]. Heart Vessels, 2024, 39(7): 597-604.
[12] 孙葵葵, 王辰, 庞宝森, 等. 急性脑卒中住院患者深静脉血栓形成危险因素分析[J]. 中华流行病学杂志, 2004,25(12): 1019-1023.
[13] VARDI M, HARAN M. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score: a rebuttal[J]. J Thromb Haemost, 2011, 9(7): 1437-1438.
[14] CAPRINI J A. Thrombosis risk assessment as a guide to quality patient care[J]. Dis Mon, 2005, 51(2/3): 70-78.
[15] 王海军, 元钰鑫, 司全金, 等. 高龄卧床高危静脉血栓栓塞症防治中国专家共识[J]. 中华老年心脑血管病杂志, 2024, 26(12): 1381-1389.
[16] ESSAT M, GOODACRE S, PANDOR A, et al. Diagnostic accuracy of D-dimer for acute aortic syndromes: systematic review and meta-analysis[J]. Ann Emerg Med, 2024, 84(4): 409-421.
[17] BARRETT L, JONES T, HORNER D. The application of an age adjusted D-dimer threshold to rule out suspected venous thromboembolism (VTE) in an emergency department setting: a retrospective diagnostic cohort study[J]. BMC Emerg Med, 2022, 22(1): 186.
[18] 王琳, 刘洋, 陆再英. 2010年欧洲心脏病学会心房颤动处理指南解读[J]. 内科急危重症杂志, 2011, 17(2): 124-128.
[19] KAHN S R, LIM W, DUNN A S, et al. Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. Chest, 2012, 141(2 Suppl): e195S-e226S.
[20] 中华医学会重症医学分会. 重症监护病房患者深静脉血栓形成预防指南[J]. 中国危重病急救医学, 2009, 21(9): 514-517.
[21] LAFAIE L, POENOU G, HANON O, et al. Anticoagulation and venous thromboembolism in patients aged 90 years and older: data from the RIETE registry[J]. J Am Geriatr Soc, 2024, 72(1): 113-125.
[22] RASCHKE R A, REILLY B M, GUIDRY J R, et al. The weight-based heparin dosing nomogram compared with a “standard care” nomogram. A randomized controlled trial[J]. Ann Intern Med, 1993, 119(9): 874-881.
[23] 朱珠, 杨鸿溢, 陈安妮, 等. 抗凝药物在肝肾功能不全患者中的临床应用进展[J]. 中国医院药学杂志, 2018,38(4): 454-458.
[24] ERKENS P M, PRINS M H. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism[J]. Cochrane Database Syst Rev, 2010(9): CD001100.
[25] 刘晓辉, 宋景春, 张进华, 等. 中国抗血栓药物相关出血诊疗规范专家共识[J]. 解放军医学杂志, 2022,47(12): 1169-1179.
[26] SHENDRE A, PARMAR G M, DILLON C, et al. Influence of age on warfarin dose, anticoagulation control, and risk of hemorrhage[J]. Pharmacotherapy, 2018, 38(6): 588-596.
[27] ABSHER R K, ELISABETH MOORE M, PARKER M H. Patient-specific factors predictive of warfarin dosage requirements[J]. Ann Pharmacother, 2002, 36(10): 1512-1517.
[28] AGENO W, GALLUS A S, WITTKOWSKY A, et al. Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. Chest, 2012, 141(2 Suppl): e44S-e88S.
[29] 王乔宇, 武明芬, 柳鑫, 等. 2021中国静脉血栓栓塞症防治抗凝药物的选用与药学监护指南[J]. 中国临床药理学杂志, 2021,37(21): 2999-3016.
[30] AGNELLI G, BULLER H R, COHEN A, et al. Oral apixaban for the treatment of acute venous thromboembolism[J]. N Engl J Med, 2013, 369(9): 799-808.
[31] INVESTIGATORS H V, BÜLLER H R, DÉCOUSUS H, et al. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism[J]. N Engl J Med, 2013, 369(15): 1406-1415.
[32] PESSÔA R L, KESSLER V G, BECKER G G, et al. Efficacy and safety of direct oral anticoagulants for acute treatment of venous thromboembolism in older adults: a network meta-analysis of randomised controlled trials[J]. Vasc Endovascular Surg, 2024, 58(6): 633-639.
[33] 张馨丹. 新型口服抗凝药在心血管病中的研究进展[D]. 重庆: 重庆医科大学, 2016.
[34] 中国老年医学学会重症医学分会, 浙江省重症医学临床医学研究中心, 严静, 等. 老年重症患者静脉血栓栓塞症预防中国专家共识(2023)[J]. 中华危重病急救医学, 2023, 35(6): 561-572.
[35] 殷敏毅, 叶开创. 急性下肢深静脉血栓形成腔内治疗专家共识[J]. 血管与腔内血管外科杂志, 2023,9(5): 513-519.
[36] 顾建平, 徐克, 滕皋军. 下肢深静脉血栓形成介入治疗规范的专家共识(第2版)[J]. 介入放射学杂志, 2019, 28(1): 1-10.
[37] VEDANTHAM S, GOLDHABER S Z, JULIAN J A, et al. Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis[J]. N Engl J Med, 2017, 377(23): 2240-2252.
[38] CONG L, HUANG L, FAN B, et al. Analysis of the efficacy of angiojet percutaneous mechanical thrombectomy combined with catheter-directed thrombolysis versus catheter-directed thrombolysis alone in the treatment of subacute iliofemoral deep venous thrombosis in elderly patients[J]. Phlebology, 2025, 40(2): 88-94.
[39] TAKASE T, IWANAGA Y, YAMASHITA Y, et al. Long-term effects of non-retrieved inferior vena cava filters on recurrences of venous thromboembolism in cancer and non-cancer patients: from the COMMAND VTE registry[J]. Eur J Intern Med, 2020, 82. DOI: 10.1016/j.ejim.2020.09.002.
[40] 李晓强, 张福先, 王深明. 深静脉血栓形成的诊断和治疗指南(第三版)[J/OL]. 中国血管外科杂志:电子版, 2017, 9(4): 250-257.
[41] 蒋鹏, 刘建龙, 贾伟, 等. 《欧洲血管外科学会(ESVS)2021年静脉血栓管理临床实践指南》临床热点解读[J]. 中国普通外科杂志, 2022, 31(6): 717-727.
[42] STEVENS S M, WOLLER S C, KREUZIGER L B, et al. Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report[J]. Chest, 2021, 160(6): e545-e608.
[43] 植艳茹, 李海燕, 陆清声. 住院患者静脉血栓栓塞症预防护理与管理专家共识[J]. 解放军护理杂志, 2021, 38(6): 17-21.
[44] 上海市肺栓塞和深静脉血栓防治联盟, 国际血管联盟中国分部护理专业委员会, 上海市护理学会外科护理专业委员会, 等. 间歇充气加压用于静脉血栓栓塞症预防的中国专家共识[J]. 中华普通外科杂志, 2022, 37(7): 549-553.
[45] 吕丽琼, 彭仁梅, 刘化刚, 等. 深静脉血栓后综合征预防护理研究进展[J]. 护理学杂志, 2024, 39(19): 120-123.
[46] KEARON C, KAHN S R, AGNELLI G, et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition)[J]. Chest, 2008, 133(6 Suppl):454S-545S.
[47] KEARON C, AKL E A, COMEROTA A J, et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9 th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. Chest, 2012, 142(2): e419s-e494s.
[48] KAHN S R, GALANAUD J P, VEDANTHAM S, et al. Guidance for the prevention and treatment of the post-thrombotic syndrome[J]. J Thromb Thrombolysis, 2016, 41(1): 144-153.

Advances in the treatment of deep vein thrombosis in the elderly

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Recommended 10

[1]	ZHANG Yidan, YANG Jian, LIU Jiao, LI Xia, GONG Li, YAO Jing. Advances in imaging diagnosis of deep vein thrombosis in the elderly [J]. Practical Geriatrics, 2025, 39(9): 871-875.
[2]	DU Haiwen, ZHANG Yidan, LI Xia, LIU Jiao, WEI Shuping. Advances in the epidemiology and risk factors of deep venous thrombosis in the elderly [J]. Practical Geriatrics, 2025, 39(9): 879-882.
[3]	QIAN Jing, YAN Xiaodi, SHEN Chaoyan, YAO Ninghua, SHI Yu, BIAN Yinzhu. Study on the expression of ANLN in tissues of elderly patients with pancreatic cancer and its mechanism of action on pancreatic cancer cells [J]. Practical Geriatrics, 2025, 39(9): 888-893.
[4]	ZHANG Yuwen, CHEN Lijian. Effects of crystalloid preloading and colloid preloading on hemodynamics and early postoperative cognitive function in elderly patients undergoing painless colonoscopy [J]. Practical Geriatrics, 2025, 39(9): 894-898.
[5]	HUANG Yong, WANG Fengfeng, SHI Bosheng, HUANG Li, WANG Zhifei. Transcutaneous acupoint electrical stimulation for postoperative pain management and gastrointestinal function recovery in elderly patients with hip fractures [J]. Practical Geriatrics, 2025, 39(9): 910-914.
[6]	LYU Wenjun, KANG Jing, MO Fei. Study on the current status and influencing factors of activity of daily living in Chinese elderly people from the perspective of health ecology [J]. Practical Geriatrics, 2025, 39(9): 915-919.
[7]	YAN Zhenlong, HUANG Ping, CHEN Meng, TAO Junjie, WANG Yuchuan, CHEN Lili, FAN Ya, LI Zehua, ZHOU Xiaotian. Revision and reliability and validity verification of the Chinese version of Identification of Seniors At Risk in the department of emergency [J]. Practical Geriatrics, 2025, 39(9): 920-923.
[8]	ZHANG Ning, GAO Xiu, KANG Lin, LIU Xiaohong. Analysis of clinical characteristics of 17 elderly patients with pulmonary actinomycosis [J]. Practical Geriatrics, 2025, 39(9): 924-928.
[9]	MO Jun, ZHANG Siping, ZHANG Huanwen, LI Jianjiang, Dannier Abulimiti, HUANG Yifei. Efficacy of selective vertebroplasty in the treatment of multi-segment vertebral osteoporotic fractures [J]. Practical Geriatrics, 2025, 39(9): 929-932.
[10]	YAO Heling, WANG Yu, LI Wansong, LUO Hongjie, LYU Xiaolei,WANG Xin, FENG Lina. Clinical value of white matter hyperintensities for overactive bladder symptom in elderly patients with cerebral small vessel disease [J]. Practical Geriatrics, 2025, 39(9): 933-936.
[11]	WANG Miaohui, FAN Xuhang, CHEN Siyao, YANG Xiaojuan. Research progress on the correlation between Alzheimer’s disease and osteoporosis [J]. Practical Geriatrics, 2025, 39(9): 937-941.
[12]	YAO Yuan, YANG Yong. Advances in the mechanisms of immunosenescence in elderly patients with non-small cell lung cancer [J]. Practical Geriatrics, 2025, 39(9): 947-951.
[13]	ZHOU Dan, WEI Kexin, DENG Shu, HE Rui. Research progress on the prevention and treatment of venous thromboembolism in elderly using artificial intelligence and wearable devices [J]. Practical Geriatrics, 2025, 39(9): 963-967.
[14]	HE Xinxin, XIE Dongmei, WANG Xiaoling, LI Ying, GAO Langli. Research progress in the application of artificial intelligence in the care for disabled elderly [J]. Practical Geriatrics, 2025, 39(8): 757-761.
[15]	JIANG Huizeng, LIU Jinna, ZHANG Dandan, ZHANG Jie. Advances of the application of artificial intelligence in fall risk management in the elderly [J]. Practical Geriatrics, 2025, 39(8): 762-767.